Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

siRNA-based nanomedicine.

Zhao J, Mi Y, Feng SS.

Nanomedicine (Lond). 2013 Jun;8(6):859-62. doi: 10.2217/nnm.13.73. No abstract available.

2.

Strategies and advances in nanomedicine for targeted siRNA delivery.

Nimesh S, Gupta N, Chandra R.

Nanomedicine (Lond). 2011 Jun;6(4):729-46. doi: 10.2217/nnm.11.15.

PMID:
21718181
3.

Eighth International Nanomedicine and Drug Delivery Symposium (NanoDDS'10).

Kabanov A, Bronich T.

J Control Release. 2011 Jul 15;153(1):1. doi: 10.1016/j.jconrel.2011.06.002. Epub 2011 Jun 7. No abstract available.

PMID:
21645563
4.

RNAi nanomedicines: challenges and opportunities within the immune system.

Weinstein S, Peer D.

Nanotechnology. 2010 Jun 11;21(23):232001. doi: 10.1088/0957-4484/21/23/232001. Epub 2010 May 13. Review.

PMID:
20463388
5.

Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.

Taratula O, Garbuzenko O, Savla R, Wang YA, He H, Minko T.

Curr Drug Deliv. 2011 Jan;8(1):59-69. Review.

PMID:
21034421
6.

Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo.

Kajimoto K, Sato Y, Nakamura T, Yamada Y, Harashima H.

J Control Release. 2014 Sep 28;190:593-606. doi: 10.1016/j.jconrel.2014.03.058. Epub 2014 Apr 30. Review.

PMID:
24794902
7.

Safety profile of RNAi nanomedicines.

Barros SA, Gollob JA.

Adv Drug Deliv Rev. 2012 Dec;64(15):1730-7. doi: 10.1016/j.addr.2012.06.007. Epub 2012 Jun 22. Review.

PMID:
22732527
8.

A review of the current status of siRNA nanomedicines in the treatment of cancer.

Resnier P, Montier T, Mathieu V, Benoit JP, Passirani C.

Biomaterials. 2013 Sep;34(27):6429-43. doi: 10.1016/j.biomaterials.2013.04.060. Epub 2013 May 30. Review.

PMID:
23727262
9.

A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis.

Shao W, Paul A, Abbasi S, Chahal PS, Mena JA, Montes J, Kamen A, Prakash S.

Int J Nanomedicine. 2012;7:1575-86. doi: 10.2147/IJN.S26891. Epub 2012 Mar 23.

10.

Nanomedicine in cancer treatment.

Yih TC, Wei C.

Nanomedicine. 2005 Jun;1(2):191-2. Review. No abstract available.

PMID:
17292078
11.

Self-assembled lipid nanomedicines for siRNA tumor targeting.

Tseng YC, Huang L.

J Biomed Nanotechnol. 2009 Aug;5(4):351-63. Review.

12.

Strategies for in vivo siRNA delivery in cancer.

Sanguino A, Lopez-Berestein G, Sood AK.

Mini Rev Med Chem. 2008 Mar;8(3):248-55. Review.

PMID:
18336345
13.

Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.

Namiki Y, Fuchigami T, Tada N, Kawamura R, Matsunuma S, Kitamoto Y, Nakagawa M.

Acc Chem Res. 2011 Oct 18;44(10):1080-93. doi: 10.1021/ar200011r. Epub 2011 Jul 26. Review.

PMID:
21786832
14.

Quantum rods as nanocarriers of gene therapy.

Aalinkeel R, Nair B, Reynolds JL, Sykes DE, Law WC, Mahajan SD, Prasad PN, Schwartz SA.

Drug Deliv. 2012 May;19(4):220-31. doi: 10.3109/10717544.2012.690001. Review.

PMID:
22643056
15.

Smart drug delivery nanocarriers with self-assembled DNA nanostructures.

Li J, Fan C, Pei H, Shi J, Huang Q.

Adv Mater. 2013 Aug 27;25(32):4386-96. doi: 10.1002/adma.201300875. Epub 2013 Jun 13. Review.

PMID:
23765613
16.

Nanomedicinal delivery approaches for therapeutic siRNA.

Keller M.

Int J Pharm. 2009 Sep 11;379(2):210-1. doi: 10.1016/j.ijpharm.2009.03.038. Epub 2009 Apr 5. Review.

PMID:
19716034
17.

siRNA delivery systems for cancer treatment.

Oh YK, Park TG.

Adv Drug Deliv Rev. 2009 Aug 10;61(10):850-62. doi: 10.1016/j.addr.2009.04.018. Epub 2009 May 5. Review.

PMID:
19422869
18.

Nanotechnology-based cancer therapeutics--promise and challenge--lessons learned through the NCI Alliance for Nanotechnology in Cancer.

Farrell D, Ptak K, Panaro NJ, Grodzinski P.

Pharm Res. 2011 Feb;28(2):273-8. doi: 10.1007/s11095-010-0214-7. Epub 2010 Aug 6.

PMID:
20814720
19.

Construction of negatively charged and environment-sensitive nanomedicine for tumor-targeted efficient siRNA delivery.

Wang Y, Xiao H, Fang J, Yu X, Su Z, Cheng D, Shuai X.

Chem Commun (Camb). 2016 Jan 21;52(6):1194-7. doi: 10.1039/c5cc09181k.

PMID:
26603479
20.

In vivo application of RNA interference: from functional genomics to therapeutics.

Lu PY, Xie F, Woodle MC.

Adv Genet. 2005;54:117-42. Review.

PMID:
16096010

Supplemental Content

Support Center